13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 72 holding rows worth $697,057,805.
- Accession
- 0001802630-23-000003
- Filer
- CIK 1802630
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 72 entries on the cover page, a total value of $697,057,805 stated on the cover page (in dollars after the unit check, H1), rows summing to $697,057,805 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EDAP TMS S A | 268311107 | SPONSORED ADR | 5,134,430 | $54,733,024 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 2,114,728 | $45,276,326 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 128,268 | $35,670,048 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 4,220,397 | $34,818,275 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,102,447 | $34,153,808 | dollars as filed | |
| Surmodics Inc | 868873100 | Common Stock | 775,311 | $26,453,611 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 908,997 | $23,942,981 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 101,850 | $22,193,115 | dollars as filed | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 745,004 | $21,076,163 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 7,363,063 | $19,806,639 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 1,014,640 | $18,618,644 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 387,950 | $18,602,203 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,210,228 | $16,955,294 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 188,217 | $14,910,551 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 2,440,843 | $14,400,974 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 39,100 | $14,304,344 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 224,550 | $14,272,398 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 287,300 | $14,224,223 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 312,500 | $14,046,875 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 26,750 | $13,701,083 | dollars as filed | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 1,376,368 | $12,524,949 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 478,302 | $11,785,361 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 46,200 | $11,636,856 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 233,116 | $11,194,230 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 3,869,392 | $9,750,868 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 94,754 | $8,830,125 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 34,550 | $8,290,618 | dollars as filed | |
| THERATECHNOLOGIES INC COM | 88338H100 | COM | 8,799,125 | $7,767,876 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 258,400 | $7,648,640 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 755,998 | $7,544,860 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 310,000 | $6,878,900 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 137,814 | $6,411,107 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 217,119 | $6,361,587 | dollars as filed | |
| ORTHOFIX MED INC | 68752M108 | COM | 295,300 | $6,062,509 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 254,700 | $5,656,887 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 220,000 | $5,599,000 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 173,447 | $5,411,546 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 110,200 | $5,349,108 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 95,000 | $5,084,400 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 24,262 | $4,905,776 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 379,000 | $4,824,670 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 40,000 | $4,529,600 | dollars as filed | |
| IMAGO BIOSCIENCES INC | 45250K107 | COM | 115,000 | $4,134,250 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 50,000 | $3,856,500 | dollars as filed | |
| BERKELEY LTS INC | 084310101 | COM | 1,330,000 | $3,564,400 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,369,003 | $3,529,814 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 310,000 | $3,487,500 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 31,100 | $3,421,000 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 238,000 | $2,815,540 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 43,500 | $2,684,820 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 39,920 | $2,620,748 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 236,000 | $2,574,760 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 70,000 | $2,550,800 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 9,600 | $2,547,360 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 69,000 | $2,262,510 | dollars as filed | |
| NEOGEN CORP | 640491106 | COM | 143,500 | $2,185,505 | dollars as filed | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 1,250,000 | $2,112,500 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 9,300 | $2,068,878 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 78,000 | $2,043,600 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 50,636 | $1,871,000 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 592,417 | $1,860,189 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 113,463 | $1,817,677 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 38,000 | $1,498,340 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 1,000,000 | $1,040,000 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 22,000 | $894,300 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 20,000 | $884,400 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 226,941 | $610,471 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 71,000 | $598,530 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 14,727 | $456,390 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 87,182 | $425,448 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 7,471 | $296,823 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 10,000 | $133,700 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-23-000003 | this filing | 2023-02-14 | acceptance time not in the bulk data set |